Ligand Pharmaceuticals LGND
NASDAQ LGND
$310.36 -3.74 (-1.19%)
At close: Sep 29, 2026 · 4:00 PM EDT

Ligand Pharmaceuticals (LGND) Net Margin (2010 - 2026)

Updated

Ligand Pharmaceuticals (LGND) posted Net Margin of 76.16% for Q2 2026, up 65.98 percentage points from 10.18% a year earlier and up 101.96 percentage points from the prior quarter.

Analysis

Ligand Pharmaceuticals (LGND) Net Margin (2010 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Net Margin at Ligand Pharmaceuticals was 67.88%, up 108.32 percentage points year-over-year; for FY2025, it was 46.42%, up 48.84 percentage points from FY2024.

  • Annual Net Margin shows a five-year change of +48.25 percentage points (FY2020 to FY2025).
  • In prior years, Ligand Pharmaceuticals' Net Margin was -2.41% in FY2024 (-42.13 pp), 39.72% in FY2023 (+56.72 pp), -17.00% in FY2022 (-40.65 pp) and 23.66% in FY2021 (+25.48 pp).
  • Quarterly Net Margin has run from a low of -124.99% in Q2 2024 to a high of 278.07% in Q1 2024 over five years.
  • On a year-over-year basis, Net Margin has increased in each of the last five quarters, with an average year-over-year change of +5.06 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Net Margin in the past five years was Q1 2024, with a gain of 182.68 percentage points; the weakest was Q1 2025, with a drop of 371.71 percentage points.
  • According to Business Quant data, Net Margin for the three prior quarters was -25.80% (Q1 2026), 75.06% (Q4 2025) and 101.57% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 21.86%
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 21.27%
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -8.04%
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 22.61%
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 18.81%
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 23.62%
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -134.51%
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -1.65%
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 32.99%
10 Ligand Pharmaceuticals 6.26 Bn 2.72 Bn - 76.16%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 76.16%
Mar 31, 2026 -25.80%
Dec 31, 2025 75.06%
Sep 30, 2025 101.57%
Jun 30, 2025 10.18%
Mar 31, 2025 -93.64%
Dec 31, 2024 -72.62%
Sep 30, 2024 -13.84%
Jun 30, 2024 -124.99%
Mar 31, 2024 278.07%
Dec 31, 2023 64.72%
Sep 30, 2023 -31.26%
Jun 30, 2023 8.69%
Mar 31, 2023 95.38%
Dec 31, 2022 -34.70%
Sep 30, 2022 0.68%
Jun 30, 2022 -1.79%
Mar 31, 2022 -42.13%
Dec 31, 2021 -9.60%
Sep 30, 2021 22.99%
API Access

Ligand Pharmaceuticals Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=LGND&period=max&api_key=YOUR_API_KEY